Bicycle Therapeutics Ltd (BCYC)
NGS · ADR · CUSIP 088786108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BCYC and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
088786108
Market Cap
Small Cap
IPO
5/23/2019 · $14.00/share
ADR Ratio
1:1
Business: Bicycle Therapeutics Ltd is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained to form two loops that stabilize their structural geometry.

Company Contact

CEO
Kevin Lee
CFO
Lee Kalowski
Investor Relations
David Borah · 617-203-8300 · david.borah@bicycletx.com
General Email
info@bicycletx.com
SEC EDGAR Filings
View filings »